European Healthtech startup funding raised during Q3 2021.
In Q3 2021, 190 European Healthtech companies raised a combined €2.8B across 192 funding rounds, up 35.7% versus Q3 2020. UK led by capital raised, and Octopus Ventures was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| CMR Surgical | Series D+ | Jul 2021 | €505M |
| Artios | Series C | Jul 2021 | €130M |
| Touchlight | Other | Sep 2021 | €107M |
| Pepgen | Other | Aug 2021 |
12 exits · €596M disclosed.
| Simbionix | Acquisition | Jul 2021 | €256M |
| Zebra Medical Vision | Acquisition | Aug 2021 | €171M |
| Dynamic Code | Acquisition | Sep 2021 | €148M |
| Jour | Acquisition | Sep 2021 | €17M |
| Phasya | Acquisition | Aug 2021 | €4.0M |
| €95M |
| T-knife | Series B | Aug 2021 | €93M |
| Beckley Psytech | Series B | Aug 2021 | €68M |
| Oviva | Series C | Sep 2021 | €68M |
| Kaia Health | Other | Jul 2021 | €65M |
| Cardior Pharmaceuticals | Series B | Aug 2021 | €64M |
| TreeFrog Therapeutics | Series B | Sep 2021 | €64M |
| AIDoc | Series C | Jul 2021 | €56M |
| Quit Genius | Series B | Jul 2021 | €54M |
| Kinarus | Other | Sep 2021 | €52M |
| Lifebit | Other | Sep 2021 | €51M |
| Anjarium Biosciences | Series A | Sep 2021 | €51M |
